KalVista Pharmaceuticals
KALV
KALV
24 hedge funds and large institutions have $63.2M invested in KalVista Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19.36% less ownership
Funds ownership: 79.46% → 60.09% (-19%)
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.29M | |
| 2 | +$3.05M | |
| 3 | +$2.31M | |
| 4 |
NC
Nexthera Capital
New York
|
+$1.76M |
| 5 |
Renaissance Technologies
New York
|
+$865K |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$1.49M | |
| 3 | -$793K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$146K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$75K |